Cerity Partners
BHVN icon

Cerity Partners’s Biohaven BHVN Stock Holding History

Cerity Partners’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Buy
161,910
+49,085
+44% +$528K ﹤0.01% 1488
2026
Q1 		$954K Buy
112,825
+65,682
+139% +$719K ﹤0.01% 1884
2025
Q4 		$532K Buy
+47,143
New +$584K ﹤0.01% 2068

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cerity Partners's BHVN Position: Q2 2026 in Review

Cerity Partners increased its Biohaven (BHVN) stake by 44% in Q2 2026, buying an estimated $528K and bringing the position to 161,910 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

Cerity Partners first reported a position in BHVN in Q4 2025 and has held it in 3 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Cerity Partners held 161,910 shares of Biohaven worth $2.41M as of Q2 2026.
  • Cerity Partners bought 49,085 Biohaven shares in Q2 2026, an estimated $528K.
  • Biohaven made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1488 holding.
  • Cerity Partners first reported a position in Biohaven in Q4 2025 and has held it in 3 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.